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We previously proposed that the keratinocyte hyper-
proliferative state in psoriatic skin results from a
combination of T cell cytokine interaction with basal
keratinocytes that exist in a primed state. We now
provide evidence that basal keratinocytes from
psoriatic uninvolved skin are in a preactivated state
with regard to their interaction with ®bronectin.
Freshly isolated basal keratinocytes (K1/K10
±) from
nonlesional psoriatic skin demonstrated a signi®-
cantly higher percentage of spreading cells 1 h after
plating on ®bronectin-coated plates than keratino-
cytes isolated from normal skin (p = 0.0002). No dif-
ferences were observed on collagen±laminin-coated
plates, however. The keratinocyte spreading on
®bronectin-coated plates involved a5b1 and aVb1
integrins. To address the potential signaling cascades
that may respond to integrin changes in psoriatic
keratinocytes, focal adhesion kinase changes were
assessed. The percentage of keratinocytes from
psoriatic uninvolved skin that exhibit positive focal
adhesion kinase staining was signi®cantly greater
than the percentage from healthy volunteers after 1 h
incubation on ®bronectin (p = 0.006). Additionally,
focal adhesion kinase isolated from uninvolved
psoriatic keratinocytes had a greater degree of tyro-
sine phosphorylation. Thus, the proliferative effect of
®bronectin in combination with T cell lymphokines
on psoriatic uninvolved basal keratinocyte progeni-
tors may be due to abnormal in vivo integrin-driven
focal adhesion kinase activity and downstream sig-
naling. Key words: focal adhesion kinase/integrin/
keratinocytes/psoriasis. J Invest Dermatol 117:1538±1545,
2001
P
soriasis is a chronic and debilitating disease whose
pathophysiologic mechanisms have not been fully
de®ned. Several emerging concepts have, however,
been de®ned as contributing to the development of
lesions and the required components for sustaining the
chronic lesions. These factors include immune cell components,
integrins/extracellular matrix proteins, and genetic predisposition
in certain individuals. An immune regulatory role in the disease has
also been demonstrated through clinical trials using immunosup-
pressive agents, such as cyclosporine A (Ellis et al, 1991), aimed at T
cell activation in response to increased antigen presenting cell
activity (Baadsgaard et al, 1987; Cooper et al, 1987; Nickoloff et al,
1988). Other therapeutics targeting T cell±antigen presenting cell
interactions con®rm the critical nature of these cell types for
maintaining keratinocyte proliferation in lesions (LFA3-TIP)
(CTLA-4-Ig) (Abrams et al, 1999).
Activated T cells may be key to keratinocyte hyperproliferation,
which is a hallmark of psoriasis, either through direct interactions
with the proliferative population or through indirect activating
effects on other cells that can modify keratinocyte proliferative
potential. The response of psoriatic keratinocytes to T cell products
such as interferon g (IFN-g), however, has been demonstrated
in vitro to differ from that of normal keratinocytes (Baker et al, 1988;
Baadsgaard et al, 1990; Bata-Csorgo et al, 1995; Jackson et al, 1999).
In psoriasis, the target of activated T cells is likely to be the basal
``stem cell'' keratinocyte (b1 integrin+ K1/K10±), whose expansion
is the source for the hyperproliferative events associated with
psoriasis (Bata-Csorgo et al, 1993). In fact, we found that the
clonogenic basal stem cell population in psoriatic uninvolved skin
(but not in normal skin) is a susceptible target of growth stimulatory
T cell lymphokines (Bata-Csorgo et al, 1995). The growth-
stimulating effect of the critical T cell lymphokine, IFN-g, on
uninvolved psoriatic, but not normal, keratinocytes is synergistic-
ally potentiated in vitro by concomitant exposure to ®bronectin.
Fibronectin is found surrounding basal keratinocytes in vivo in the
epidermis of both involved (Fyrand, 1979; Ting et al, 2000) and
uninvolved (Bata-Csorgo et al, 1998) skin. In addition, cellular
®bronectin is overexpressed at the basement membrane zone
(BMZ) in psoriatic skin (Ting et al, 2000). Activated lining (BMZ)
macrophages overproduce the EDA isoform of ®bronectin in
psoriasis,1 which has enhanced RGD exposure for integrin binding
(Hino et al, 1996; Manabe et al, 1997, 1999). This is an important
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point because integrin interactions critically regulate the keratino-
cyte basal cell populations. This has been shown in human
examples as well as in transgenic mouse experiments (Carroll et al,
1995; Bata-Csorgo et al, 1998; Romero et al, 1999). The basis of
differential regulation of keratinocytes by integrin-binding matrices
in psoriasis, however, has not been examined.
In this paper, we ask whether or not a more proximal response to
extracellular matrix could be identi®ed in basal keratinocytes
isolated from psoriatic uninvolved skin compared with nonpsoriatic
basal keratinocytes. Our focus on uninvolved skin is to address
possible upstream or triggering pathways that may contribute to the
development of the hyperproliferative responsiveness of psoriatic
keratinocytes. Our hypothesis is that uninvolved skin contains basal
keratinocytes that are hyper-reactive to the overexpressed ®bro-
nectin EDA at the dermal±epidermal junction (DEJ), which would
create a ``primed'' state in which clonogenic cells enter the cell
cycle under the in¯uence of T cell lymphokines. Therefore, these
mechanisms would be central to the early developing plaque
response and would be critical to the development of hyper-
proliferation signaling.
Using fresh ex vivo keratinocytes from uninvolved psoriatic skin,
we demonstrate that the psoriatic uninvolved keratinocytes are able
to attach and spread on ®bronectin more ef®ciently than
keratinocytes isolated from nonpsoriatic tissue. We also demon-
strate that ®bronectin is a preferred substrate for this responsiveness
of uninvolved psoriatic keratinocytes versus collagen and laminin,
which have no such effect. We further show that molecules
involved in integrin signaling via ®bronectin are activated in
psoriatic keratinocytes compared with keratinocytes from non-
psoriatic skin. Speci®cally, elevated focal adhesion kinase (FAK)
was rapidly assembled in response to ®bronectin, and elevated levels
of phosphorylated FAK were found in the psoriatic uninvolved
epidermis. These observations lead to the conclusion that
keratinocytes from a psoriatic environment exist in a ``preactivated''
responsive state to signaling through integrin interactions such as
a5b1 integrin signaling. This predisposition to activation through
integrin signaling may account for the hyperproliferation and rapid
upregulation of keratinocyte proliferation that leads to a psoriatic
plaque under conditions of immune activation or wounding.
MATERIALS AND METHODS
Human subjects Informed consent was obtained from each subject,
and the Institutional Review Board of University Hospitals of Cleveland
approved all of the procedures. Keratome biopsies were taken from
nonlesional buttock area skin of psoriasis patients and normal volunteers.
A medication-free period of 1 mo for oral and 2 wk for topical
treatment was required in both groups before the procedure.
Epidermal cell suspension preparation Psoriatic uninvolved and
normal keratomes were placed in dispase (Collaborative Biomedical
Products, Bedford, MA) at 4°C overnight. Following incubation, the
epidermis was removed from dermis. The epidermal sheet was placed
into Cell Dissociation Buffer (Gibco BRL, Gaithersburg, MD) with
0.1% DNase (Deoxyribonuclease I, Sigma, St. Louis, MO) at 37°C for
45 min. The epidermis was minced and the cell suspension was ®ltered
through a 100 mm nylon mesh; cells were washed three times with
Hanks' balanced salt solution, 1% fetal bovine serum (FBS), and
resuspended in keratinocyte basal medium (KBM; Gibco BRL) with 1%
FBS (Hy-clone, Logan, UT).
Short-term adhesion assay 60 3 15 mm Petri dishes were coated
with 100 mg per ml ®bronectin (bovine plasma, Sigma) in phosphate-
buffered saline (PBS) overnight at 4°C. Plates were washed with PBS,
then incubated with heat-denatured (56°C, 1 h) bovine serum albumin
(BSA) (99% bovine albumin, Sigma) at 37°C for 1 h and washed with
PBS. 10 3 106 freshly separated epidermal cells in 3 ml KBM + 1% FBS
medium were plated into each dish. After a 2 h incubation at 37°C and
5% CO2, nonadherent cells were removed from the plates and the
adherent cells were collected after brief trypsinization. Cells were then
®xed in cold 70% ethanol and kept at ±20°C overnight before staining.
Anti-K1/K10 (antiepithelial keratin clone AE2, ICN Biomedicals, Costa
Mesa, CA) 1:50 and mouse IgG1 (Kappa MOPC 21, Sigma) at the same
concentration as the antibody were used in a standard indirect staining
procedure (Bata-Csorgo et al, 1993). The secondary antibody, ¯uorescein
isothiocyanate (FITC) conjugated goat antimouse IgG1 (BMB,
Indianapolis, IN) was used at 1:100 dilution. All samples were stained for
DNA content with propidium iodide (50 mg per ml) and RNase (100 U
per ml) (Sigma) as previously described (Bata-Csorgo et al, 1993). Flow
cytometry was performed using an Epics Elite ¯ow cytometer (Coulter
Cytometry, Hialeah, FL). Forward and 90°C light scatter was used for
gating out debris and cell aggregates were eliminated based on the ratio
of integrated to peak ¯uorescence of propidium iodide. Listmode data
were analyzed using Elite software (Coulter Corporation).
Ex vivo keratinocyte culture Four-well Laboratory-Tek glass culture
slides (Nunc, Naperville, IL) were coated with either ®bronectin (bovine
plasma, Becton Dickinson Labware, Bedford, MA) (25 mg per ml) or
collagen (Type IV, Sigma) (25 mg per ml) plus laminin (Becton
Dickinson Labware) (25 mg per ml) at room temperature overnight
followed by blocking with Dulbecco's modi®ed Eagle's medium
(DMEM, Gibco) containing 0.025% heat-denatured BSA at 37°C for
1 h. After washing, fresh epidermal cells were incubated on ®bronectin-
or collagen±laminin-coated slides (0.7 3 106 per chamber) for 1 h, 4 h,
and 24 h at 37°C. Nonadherent cells were removed by gently washing
with PBS. Adherent cells were ®xed in 4% paraformaldehyde/PBS for
2 min at room temperature and stored at 4°C until staining. Yields and
viability of the adherent keratinocyte populations were monitored for
quality control of the preparations.
Quantitation of spreading by epidermal basal keratinocytes The
basal keratinocyte population was visualized on glass slides using anti-K1/
K10 to exclude transiently amplifying cells and differentiated keratino-
cytes, and with antivimentin to exclude melanocytes and Langerhans
cells (Bata-Csorgo et al, 1993). Fixed slides were blocked with 2% BSA
in PBS at 37°C for 30 min, washed with PBS, and incubated with
primary IgG1 monoclonal antibodies: anti-K1/K10 (1:150) and anti-
vimentin (Clone V9 IgG1, ICN Biomedical) (1:150) [control slides were
stained with isotype mIgG1 (Kappa MOPC 21, Sigma) (1:150)] at 37°C
for 45 min. Slides were then incubated with secondary antibody, FITC-
conjugated goat-antimouse IgG1 (1:150), at 37°C for 30 min. After
three washes with PBS, the slides were stained with rhodamine-
phalloidin for identifying F-actin (Molecular Probes, Eugene, OR) (1
unit per slide) at room temperature for 20 min to visualize the
micro®lament pattern of cells undergoing the spreading response
(Flickinger and Culp, 1990). In general, at least 200 of K1/K10
± and
vimentin± adherent keratinocytes were counted and photographed by
¯uorescence microscopy (Axiophot; Carl Zeiss, Thorwood, NY). Cells
undergoing the spreading response were de®ned by the following
criteria: actin condensation at the periphery of three sites or more per
cell, or cytoplasmic extensions with ¯attening > 50% at the periphery of
the cell.
In some experiments, fresh epidermal cell suspensions (2 3 106 per
ml) were incubated with anti-integrin blocking antibodies to determine
the integrin pairs involved in the response: anti-a5 (CD49e, Clone
ILA1, Pharmingen, San Diego, CA) (25 mg per ml), anti-aV (CD51,
Clone AMF7, Immunotech, Westbrook, ME) (25 mg per ml), anti-b1
(CD29, Clone Lia 1
2
, Immunotech) (25 mg per ml), or isotype mIgG1
(Sigma) (25 mg per ml), at 4°C for 1 h before incubating fresh epidermal
cells on ®bronectin- or collagen±laminin-coated slides. After 1, 4, or
24 h at 37°C, nonadherent cells were removed, and adherent cells were
®xed in 4% paraformaldehyde/PBS for 2 min at room temperature.
Fixed slides were blocked with PBS plus 2% BSA at 37°C for 30 min
and stained with primary monoclonal antibody antivimentin (mIgG2a,
BMB) (5 mg per ml) or isotype mIgG2a (clone UPC 10, Sigma) (1 mg
per ml) as a control at 37°C for 45 min. This was followed by secondary
antibody anti-mIgG2a FITC (BMB) (1:150) at 37°C for 30 min and
staining with rhodamine-phalloidin. The vimentin± and rhodamine-
phalloidin+ spreading keratinocytes were counted and photographed as
described above.
FAK analysis on spreading cells To identify p125FAK formation and
localization to actin condensation sites, ®xed slides were blocked with
PBS containing 2% BSA at 37°C for 30 min, and then incubated with
either anti-FAK (mIgG1, Transduction Laboratories, Lexington, KY)
(1:1500) or isotype mIgG1 (Kappa MOPC, Sigma) (1:5000) at 37°C for
1 h. Binding of antibodies was detected by incubation with biotinylated
goat anti-mIgG1 (Caltag Laboratories, South San Francisco, CA)
(1:1000) at 37°C for 45 min, followed by TSATM-Direct Tyramide
Signal Ampli®cation kit (NEN Life Science Products, Boston, MA).
Actin was visualized with rhodamine-phalloidin (Molecular Probes) (1
unit per slide).
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Immunoprecipitation and Western blot analysis of p125FAK and
tyrosine phosphorylation of FAK Fresh epidermal cells (or A431
keratinocytes as a positive control) were lyzed on ice in modi®ed RIPA
buffer containing 50 mM Tris, pH 7.4, 150 mM NaCl, 1 mM
ethylenediamine tetraacetic acid, 1% Nonidet P-40, 0.25% deoxycholate,
2.5 mM sodium pyrophosphate, 2 mM sodium vanadate, 20 mM b-
glycerophosphate, 5 mg per ml leupeptin/aprotinin, and 1 mM
phenylmethylsulfonyl ¯uoride for 45 min. Total cell lysates were cleared
by centrifugation at 16,000g for 10 min at 4°C. Protein concentration in
the lysates was determined using the Bio-Rad protein assay (Bio-Rad
Laboratories, Hercules, CA). Cell lysates (500 mg per 500 ml) from each
sample were ®rst incubated with anti-FAK monoclonal antibody (1:50)
at 4°C overnight, followed by addition of 80 ml GammaBindG
Sepharose (Pharmacia Biotech AB, Uppsala, Sweden) at 4°C overnight.
Proteins were separated by sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE; 8% Tris-glycine gel) (Novex, San Diego,
CA) and transferred to nitrocellulose membranes (Novex). In all blotting
studies, equal protein (lysates or immunoprecipitates) from different
experimental samples was loaded into each lane. Nonspeci®c binding
sites on the nitrocellulose were blocked with 5% non-fat dry milk in
Tris-buffered saline and subsequently incubated with primary antibodies:
anti-FAK (1:250), PY20 (anti-phosphotyrosine monoclonal antibody
IgG1, Transduction Laboratories) (1:1000), or 4G10 (anti-phospho-
tyrosine monoclonal antibody IgG2bk, Upstate Biotechnology, Lake
Placid, NY) (1:1000) for 1 h. The membranes were washed and
incubated with sheep antimouse IgG horseradish peroxidase linked
secondary antibody (Amersham Life Science, Cleveland, OH) (1:3000)
for 1 h. After washing, the labeled proteins were visualized using a
chemiluminescence detection system. Densitometric quantitation was
carried out using OPTIMAS image software.
Statistical analysis Paired two-tailed Student's t test was used for
comparison of different treatment groups.
RESULTS
Increased a5 expression on psoriatic uninvolved basal
keratinocytes results in only marginal increases in
adherence to ®bronectin To determine whether the elevated
a5 integrin expression that we had previously observed in psoriatic
uninvolved basal keratinocytes (Bata-Csorgo et al, 1998) results in
enhanced adhesive function of such cells, we measured short-term
(2 h) adherence to ®bronectin under conditions that permitted only
®bronectin binding of cells. Epidermal cells from normal versus
psoriasis uninvolved skin were loaded with calcein-AM (Molecular
Probes), which becomes ¯uorescent upon metabolism by live cells,
and plated in 96-well plates coated with ®bronectin. Standard curves
were established using a ¯uorimeter. Viable adherent cells did not
differ between normal and psoriatic epidermal cells, with 61% of
control epidermal cells adhering, versus 60% of psoriatic epidermal
cells (data not shown). The composition of ®bronectin adherent cells
may differ slightly, however; ¯ow cytometry [performed as
previously described (Bata-Csorgo et al, 1995)] of the released
adherent cells revealed that, compared to 40% 6 2% of K1/K10 ±
cells in normal cells, psoriatic uninvolved cells contained 55% 6 6%
of K1/K10 ± cells (n = 4). Increased K1/K10 ± cells in psoriatic
uninvolved ®bronectin adherent epidermal cells were observed in
four of four experiments, but the mean values were not statistically
signi®cant from those observed for normal K1/K10 ± cells. Thus,
elevated a5b1 expression does not result in an increased adhesion of
the overall psoriatic uninvolved epidermal cell population, although
there may be some enrichment of K1/K10 ± basal cells.
Fresh psoriatic uninvolved basal keratinocytes exhibit
signi®cantly higher competence of spreading on
®bronectin than those from normal individuals We next
determined whether the ability of freshly isolated psoriatic
uninvolved basal keratinocytes to spread on ®bronectin, which is
regulated by ®bronectin receptors such as a5, is affected. Fresh
keratinocytes were incubated on either ®bronectin- or collagen±
laminin-coated slides for 1 h, 4 h, and 24 h. The response of the
basal keratinocyte population was determined by excluding from
analysis the K1/K10
+ differentiated cells and vimentin+ Langerhans
cells and melanocytes (Bata-Csorgo et al, 1995). The K1/K10
±
vimentin± adherent cells (basal keratinocytes) that were derived
from psoriatic uninvolved skin and incubated on ®bronectin
contained a high frequency of cells that exhibited multiple
cytoplasmic extensions and ¯attening of the cell body in
conjunction with actin condensation points at the periphery
(Fig 1A, c). By contrast, the majority of normal cells on either
®bronectin or collagen±laminin exhibited a round, non¯attened
appearance without extensions (Fig 1A, a, b). Such cell spreading
was not observed among K1/K10
+ vimentin+ cells at this time
point, indicating the response was mainly among the basal
keratinocyte population. The robust spreading response of the
psoriatic basal keratinocyte population upon exposure to
®bronectin for only 1 h appeared selective to ®bronectin and not
to collagen±laminin (Fig 1A, d). Grouped data are shown in
Fig 1(B) and reveal signi®cant differences in this extremely rapid
cell spreading response (1 h). The percentage of spreading cell
numbers in psoriatic uninvolved basal keratinocytes on ®bronectin-
coated slides was 52.4 6 7.5 vs 13 6 4.3 in psoriatic uninvolved
basal keratinocytes on collagen±laminin-coated slides (p = 0.0001,
n = 12) and vs 15.9 6 3.2 in normal basal keratinocytes on
®bronectin-coated slides (p = 0.0002, n = 10). In contrast to the
enhanced rapid responsiveness of fresh ex vivo psoriatic uninvolved
basal keratinocytes to ®bronectin relative to collagen±laminin,
there is no difference in responsiveness of normal basal keratino-
cytes to ®bronectin-coated slides (15.9 6 3.2% spread) compared
with collagen±laminin-coated slides (13.9 6 7% spread) (Fig 1B).
This indicated that psoriatic basal keratinocytes from uninvolved
skin carry into fresh ex vivo culture a preactivated hyper-
responsiveness to ®bronectin.
To determine whether or not this differential hyper-responsive-
ness was detectable at later time points, the 1 h response was
compared to the response at 4 h and 24 h. By 4 h, normal
keratinocytes have begun to spread on both ®bronectin and
collagen±laminin, and exceeds 80% of the attached basal keratino-
cyte population by 24 h (Table I). There is no difference between
®bronectin or collagen±laminin, nor any difference between
normal and psoriatic uninvolved basal keratinocytes at these later
points of in vitro culture. Whether the keratinocytes have modi®ed
the matrix substrate at this time or whether normal keratinocytes
have acquired a ``wound'' phenotype via integrin activation is
unknown. Taken together, then, these results indicate that psoriatic
basal keratinocytes, which are not yet in cell cycle, do, however,
carry an accelerated state of selective ®bronectin responsiveness into
fresh ex vivo culture. Because ®bronectin can also, in conjunction
with T cell lymphokines, induce cell cycle entry in psoriatic
progenitors (Bata-Csorgo et al, 1998), it appears that ®bronectin
responsiveness precedes and may confer ®bronectin and T cell
stimulated proliferation.
Integrins a5, aV, and b1 are involved in the enhanced
spreading of psoriatic uninvolved keratinocytes on
®bronectin In order to determine whether and which
integrins are involved in the spreading response to ®bronectin in
psoriatic uninvolved basal keratinocytes, blocking antibodies to
integrin binding were utilized. Fresh epidermal cell suspensions
from uninvolved psoriatic skin were incubated with the indicated
anti-integrin antibodies at 4°C for 1 h before epidermal cells were
incubated on ®bronectin-coated slides and the adherent cells were
stained to determine spreading responses. Isotype control antibody-
incubated cultures exhibited spreading responses (49% of adherent
vimentin± phalloidin+ cells) that were quite similar to cultures
without IgG (Table I, Fig 1B). Used alone as a single antibody for
blocking of spreading, anti-a5 (103% 6 3% of isotype control),
anti-aV (125% 6 26% of isotype control), and anti-b1 (120% 6
28% of isotype control) antibodies did not modify the spreading
response at 1 h (Fig 2). That ®bronectin integrins are indeed
critically involved in the psoriatic enhanced spreading response is
indicated by the robust inhibition that occurred when either anti-
a5 or anti-aV and anti-b1 were used in combination (60% 6 11%
of isotype control or 40% inhibition, p = 0.01 relative to a5 alone)
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(n = 3) (Fig 2). Similarly anti-aV + b1 was inhibited to
40% 6 4% of isotype control (60% inhibition) (p = 0.04 relative
to aV alone) (n = 2) (Fig 2).
The reduced spreading was not simply due to an experimental
artifact of blocking adhesion of keratinocytes to the culture plates.
Determination of the number of adherent cells pretreated with
isotype control or anti-integrin antibody showed no difference in
the total number of attached cells between isotype or antibody
treated keratinocytes for epidermal cells from normal skin (61%
adherence vs 67% adherence) or from psoriatic skin (60% adherence
vs 67% adherence, isotype versus antibody treated, respectively).
Thus, b1 ®bronectin receptor integrin mediation of spreading is
consistent with elevated a5b1 expression in psoriasis (Pellegrini et
al, 1992; Bata-Csorgo et al, 1998).
Enhanced ®bronectin receptor-mediated spreading by
psoriatic uninvolved fresh keratinocytes leads to increased
FAK assembly To determine and quantitate FAK localization,
®xed slides were stained with primary anti-FAK monoclonal
antibody followed by secondary FITC conjugated goat antimouse
IgG1 and rhodamine-phalloidin. After staining, the percentage of
FAK positive cells, as a percentage of phalloidin positive attached
cells, was counted. Consistent with the enhanced spreading
response at 1 h, ®bronectin adherent psoriatic uninvolved
epidermal cells exhibited numerous FAK staining points in the
cell extensions of ¯attened cells previously shown to be K1/K10
±
vimentin± basal keratinocytes (Fig 1A, c; Fig 3A, a). Some
punctate FAK staining of the cell periphery was also noted in
psoriatic uninvolved cells on collagen±laminin (Fig 3A, b), and to
an even lesser extent on normal cells (Fig 3A, c). The percentage of
®bronectin-induced FAK positive cells in psoriatic uninvolved
epidermal cells was 43.7% 6 8.4% compared with 6.6% 6 2.6% of
normal epidermal cells (p = 0.006, n = 3) (Fig 3B). Although
psoriatic epidermal cells demonstrated somewhat more FAK on
collagen±laminin than normal cells, this was markedly less than that
induced by ®bronectin [psoriatic uninvolved keratinocytes on
Figure 1. Enhanced spreading of basal keratinocytes from
psoriatic uninvolved relative to normal epidermis on ®bronectin
but not collagen±laminin. (A) Fresh epidermal cells from psoriatic
uninvolved (pso-uni) and normal epidermis were incubated on either
®bronectin- or collagen±laminin (Co + La) coated slides for 1 h. The
pattern elicited by staining with rhodamine-phalloidin, K1/K10
+, and
vimentin+ is shown in keratinocytes obtained from normal skin on
®bronectin (a) and on collagen±laminin (b), and in keratinocytes
obtained from psoriatic uninvolved skin on ®bronectin (c) and on
collagen±laminin (d). Whereas K1/K10 ± vimentin
± round cells without
condensed actin at the periphery dominate in cultures of normal
epidermal cells or psoriatic uninvolved epidermal cells in collagen±
laminin, the majority of psoriatic uninvolved K1/K10
± vimentin± cells
exhibit spreading as de®ned by our criteria detailed in Methods (c). (B)
The percentages of rhodamine-phalloidin+, K1/K10
±, and vimentin±
spreading cells are shown as open bars for normals, and a hatched bar for
basal keratinocytes from psoriatic uninvolved skin. Cumulative data
(n = 10±12) are expressed as mean 6 SEM.
Table I. Uninvolved psoriatic basal keratinocytes exhibit an
accelerated spreading response to ®bronectin
Normal Psoriasis uninvolved
FNa Co + Lab FN Co + La
1 h 15.9 6 3.2c 13.9 6 7.0 52.4 6 7.5 13 6 4.3
4 h 52.1 6 6.2 64.1 6 3.8 48.9 6 7.2 62 6 6.6
24 h 82.3 6 5.3 86.5 6 5.3 76.5 6 5.3 84.2 6 4.5
aFN, ®bronectin.
bCo + La, collagen + laminin.
cPercentages of spreading basal keratinocytes in total attached basal keratinocytes.
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®bronectin 43.7% 6 8.4% vs collagen±laminin 4.2% 6 2.6%
(p = 0.005, n = 3)] (Fig 3B). At 4 h the FAK positive cell
number in psoriatic uninvolved epidermal cells on ®bronectin
was 29.8% 6 13.9%. This was elevated relative to psoriatic
uninvolved epidermal cells on collagen±laminin, 7% 6 2.6%, and
normal cells on ®bronectin, 4.1% 6 2.8% (Table II). At 24 h,
these values were 41.6% 6 17.3%, 15.5% 6 6.2%, and
9.6% 6 6.2%, respectively (Table II). These data indicate that
preferential psoriatic ®bronectin integrin receptor mediated
spreading was probably preceded by an enhanced and more
proximal step of FAK assembly in psoriatic uninvolved basal
keratinocytes.
FAK in freshly isolated psoriatic uninvolved epidermal cells
prior to ex vivo ®bronectin exposure contains elevated levels
of phosphotyrosine by immunoblot and immunoprecipita-
tion The enhanced and accelerated ®bronectin spreading and
FAK response of psoriatic uninvolved progenitor keratinocytes may
re¯ect integrin preactivation in vivo (inside-out integrin af®nity
increase) via the increased deposition of EDA+ ®bronectin at the
DEJ and epidermal basal layer in uninvolved skin (Ting et al, 2000).
If ®bronectin is triggering overexpressed ®bronectin integrin
receptors such as a5 (Pellegrini et al, 1992; Bata-Csorgo et al,
1998; Ting et al, 2000), then an increase in FAK phosphorylation
may be detectable as a signature of such signaling. Fresh epidermal
cell suspensions were immediately lysed and separated by SDS-
PAGE to localize p125FAK. No alteration in total FAK protein
between A431 cells, normal epidermis, and psoriatic uninvolved
epidermis was detected (Fig 4A). After stripping, the membranes
were reprobed with antiphosphotyrosine, PY20 (1:500), and
densitometric quantitation of FAK phosphotyrosine was calcula-
ted. A signi®cant increased expression of FAK phosphotyrosine was
observed in psoriasis uninvolved epidermis versus that of normals
(p = 0.01) (Fig 4A). To corroborate that the PY20 detection at
p125 was indeed FAK, FAK immunoprecipitates were electro-
phoresed and visualized with antiphosphotyrosine monoclonal
antibody 4G10. As with PY20 on whole cell lysates, 4G10 staining
of FAK immunoprecipitates again show increased levels of
phosphorylated p125FAK in psoriatic uninvolved epidermis as
compared to normals (Fig 4B) (p = 0.02). Taken together, these
data are consistent with the hypothesis that integrins are triggered
in vivo in psoriatic uninvolved epidermis, and with the concept that
such triggering is not only assembling and phosphorylating FAK,
but also creating a heightened responsiveness (preactivation/
increased integrin ®bronectin receptor af®nity) to ®bronectin
upon ex vivo challenge.
DISCUSSION
We previously demonstrated that ex vivo cell growth of basal
psoriatic uninvolved keratinocytes is controlled in part by the
interaction of ®bronectin and a5 integrin (Bata-Csorgo et al, 1998).
Additionally, ®bronectin was shown to be capable of enhancing the
ex vivo proliferative response of psoriatic uninvolved, but not
normal, basal keratinocytes to IFN-g. Whether this response to
®bronectin is an intrinsic response on the part of the psoriatic
uninvolved in vivo keratinocyte, however, has not been deter-
mined. In this report, we examined the ability of freshly isolated
uninvolved psoriatic basal keratinocytes to attach and spread on
various extracellular matrices compared with keratinocytes from
nonpsoriatic individuals. We further assessed the focal adhesion
formation of uninvolved psoriatic keratinocytes and the level of
phosphorylation of FAK as an indication of FAK activity.
All indications are that basal keratinocytes, isolated from psoriatic
uninvolved tissue, are in a preactivated state. By this, we mean that
keratinocytes isolated from psoriatic uninvolved tissue rapidly
initiate spreading in less than 1 h to ®bronectin compared with a
collagen±laminin mixture, whereas normal keratinocytes do not
demonstrate either rapid spreading or differential spreading. This
experiment examined speci®cally the potential of the basal
keratinocyte population, which was identi®ed by virtue of its
K1/K10, vimentin, and rhodamine-phalloidin staining pattern. This
keratinocyte cell population comprises the clonogenic progenitor
``stem'' cell population that we have previously identi®ed to have
upregulated a5b1 staining in nonlesional skin (Bata-Csorgo et al,
1998) relative to normal keratinocytes. Thus, in combination with
our previously published data, upregulated ®bronectin receptors on
basal keratinocytes are likely to be mediating the spreading response
to ®bronectin, probably through binding and activation of the a5,
aV, and b1 integrins. This is supported by our demonstration that
both a5 and aV integrins in combination with b1 integrin are
involved in basal keratinocyte spreading on ®bronectin.
As integrin mediated binding to extracellular matrices has been
demonstrated to lead to focal adhesion formation (Guan, 1997a;
1997b) and activation of FAK (Kornberg et al, 1991; Guan and
Shalloway, 1992), we also examined the expression of the FAK
molecule. Concomitant with increased spreading on ®bronectin,
we found elevated levels of FAK in psoriatic uninvolved but not
normal keratinocytes 1 h after spreading on ®bronectin. In
addition, freshly isolated epidermal cells from psoriatic uninvolved
skin were shown to express FAK in a more highly phosphorylated
state. Given the rapid (1 h) response for spreading on ®bronectin
and increased FAK expression by such cells as well as increased
phosphorylation of FAK isolated from freshly prepared psoriatic
uninvolved epidermal cells, it appears that basal nonlesional
keratinocytes exist in vivo in a preactivated state.
Even though the differential spreading response of psoriatic basal
keratinocytes compared to normal keratinocytes on ®bronectin was
extremely robust, the differences between these basal keratinocytes
in their initial attachment to ®bronectin was increased but not in a
statistically signi®cant manner. This may re¯ect the state of integrin
activation (Garcia et al, 1998) and/or the location on the cell of the
activated ®bronectin receptor (Penas et al, 1998). Both activated b1
integrins (Penas et al, 1998) and talin, a member of the focal
adhesion complex (Magaudda et al, 1997), have been shown to be
redistributed in psoriatic skin. In normal skin, activated b1 integrins
were found distributed all over the basal keratinocytes, whereas in
psoriatic skin activated b1 integrins were found restricted to the
DEJ. Talin was found in a continuous bandlike pattern along the
dermal side of normal basal keratinocytes, whereas psoriatic basal
keratinocytes showed a discontinuous expression of talin at the
DEJ. This suggests that the psoriatic basal keratinocytes at their
Figure 2. a5b1 and aVb1 integrins mediate psoriatic uninvolved
basal keratinocyte spreading responses. Fresh epidermal cell
suspensions were incubated with anti-a5, aV and b1 antibodies at 4°C
for 1 h before incubation on ®bronectin at 37°C for 1 h. After staining
for phalloidin and vimentin, the rhodamine-phalloidin+ and vimentin±
spreading cells were counted. The rhodamine-phalloidin+ and vimentin±
spreading cells following anti-integrin blocking antibody treatment are
expressed as a percentage of isotype control. Data are shown as the mean
6 SEM, n = 2±3.
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point of contact with the DEJ may already possess clustered
activated ®bronectin receptors in a state ready to form focal
adhesion contacts immediately upon contact with ®bronectin
in vitro, whereas suf®cient activated ®bronectin receptors may be
present homogeneously distributed around the cell membrane of
normal basal keratinocytes to mediate adherence to ®bronectin but
not rapidly initiate a spreading state.
We further demonstrate here that the differential effect on
binding of basal keratinocytes to extracellular matrices is a time-
dependent response. The difference between binding of unin-
volved psoriatic keratinocytes to collagen±laminin or ®bronectin is
not apparent if the cells are checked at later time points, as well as
the difference between nonlesional keratinocytes and normal
keratinocytes binding to ®bronectin at these later time points (4±
24 h). This indicates that all basal keratinocytes are capable of
upregulating the integrin mediated spreading response, given a
suf®cient amount of contact time with the extracellular matrix.
Thus, the delayed time points are more dif®cult to interpret
because the keratinocytes quickly begin producing their own
matrix, including the potent stimulator EDA ®bronectin, which
may in fact convert normal keratinocytes to a ``wound/psoriatic''
phenotype by 4±24 h. Given the rapid (1 h) response for spreading
and FAK induction, it appears that basal nonlesional keratinocytes
are already in this preactivated state in vivo. This preactivated state
may allow these basal cells to more rapidly interact with
extracellular matrix changes that occur in the psoriatic environ-
ment. Interaction with a more stimulatory extracellular matrix may
result in signaling propagation within basal keratinocytes that results
in hyperproliferation of the cells. An alternative explanation for the
rapid attachment and spreading of basal psoriatic keratinocytes may
Figure 3. Enhanced FAK expression by psoriatic uninvolved
(pso-uni) basal keratinocytes on ®bronectin (FN) but not
collagen±laminin (Co + La). (A)Fresh epidermal cells from psoriatic
uninvolved and normal epidermis were incubated on either ®bronectin-
or collagen±laminin-coated slides for 1 h. After staining for FAK and
phalloidin, FAK positive staining cells were visualized as spread cells with
bright green ¯uorescent points within cytoplasmic extensions and at the
condensations of actin micro®laments stained with rhodamine-phalloidin.
(a) Psoriatic uninvolved epidermal cells on ®bronectin-coated slides; (b)
psoriatic uninvolved epidermal cells on collagen±laminin-coated slides; (c)
normal epidermal cells on ®bronectin-coated slides. (B)Cumulative data
from FAK positive staining cell numbers are shown as open bars for
epidermal cells obtained from normal subjects and hatched bars for
epidermal cells obtained from psoriatic uninvolved patients. Bars
represent mean 6 SEM, n = 3.
Table II. Differential expression of FAK by psoriatic
uninvolved versus normal adherent keratinocytes plated on
®bronectin
Normal Psoriasis uninvolved
FNa Co + Lab FN Co + La
1 h 6.6 6 2.6c 1.2 6 1 43.7 6 8.4 4.2 6 2.6
4 h 4.1 6 2.8 3.2 6 2.5 29.8 6 13.9 7 6 2.6
24 h 9.6 6 6.2 5 6 1.4 41.6 6 17.3 15.5 6 6.2
aFN, ®bronectin.
bCo + La, collagen + laminin.
cPercentages of adherent keratinocytes staining for FAK.
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be lengthy exposure of basal keratinocytes to elevated levels of
EDA ®bronectin in psoriatic uninvolved skin compared to
keratinocytes derived from normal skin.
Several recent papers have indicated that interaction with
®bronectin and modi®ed splice-in EDA+ ®bronectin can result in
cell cycle induction and mitogenic signaling (Bourdoulous et al,
1998; Manabe et al, 1999). Further, other investigators have also
shown that speci®c conformations of ®bronectin can affect cell
cycle progression and stimulation (Garcia et al, 1999). Integrin
mediated binding to extracellular matrices has been demonstrated
to lead to focal adhesion formation, although the exact mechanism
responsible for this association has not been identi®ed (Guan,
1997a; Guan, 1997b). It is thought that some of the earliest
signaling events that result from the formation of the focal adhesion
arise through FAK signaling (Kornberg et al, 1991; Guan and
Shalloway, 1992). FAK signaling following formation of a focal
adhesion results in rapid tyrosine phosphorylation of FAK and
association of FAK with several other intracellular signaling
molecules, including Src family kinases (Xing et al, 1994), the
adaptor molecules Grb2 and p130Cas (Polte and Hanks, 1995;
Schlaepfer et al, 1997), and phosphatidylinositol 3-kinase (Chen and
Guan, 1994). These interactions with other signaling molecules are
believed to result in the ability of the cell to respond rapidly to
extracellular in¯uences and to react in an appropriate manner.
We show here that psoriatic keratinocytes possess elevated levels
of FAK and that these elevated levels of FAK may mediate
functional differences between psoriatic keratinocytes and normal
keratinocytes in as far as spreading on extracellular matrices. It also
appears that, unlike spreading, FAK expression does not increase in
normal cells to the level achieved in psoriatic cells. This difference
may infer a FAK response in psoriatic cells to ®bronectin that will
not occur in normal cells even over time of integrin binding. It has
been suggested that activation of FAK is not necessarily dependent
on integrin activation or even focal adhesion formation (Lyman et
al, 1997). In conclusion, the identi®cation in psoriatic uninvolved
skin keratinocyte stem cells/progenitors of a heightened respon-
siveness to ®bronectin and an even more proximal elevated FAK
activity provides insight to the clinical observations of the
propensity of psoriatic uninvolved skin to develop psoriatic lesions
upon triggering by wounding or immunologic stimulation. These
®ndings suggest novel avenues of therapeutic intervention.
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